Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Shares Issued (2021 - 2025)

Journey Medical's Shares Issued history spans 5 years, with the latest figure at $132000.0 for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued changed N/A year-over-year to $132000.0, compared with a TTM value of $350000.0 through Dec 2025, up 67.46%, and an annual FY2025 reading of $350000.0, up 67.46% over the prior year.
  • Shares Issued for Q4 2025 was $132000.0 at Journey Medical, up from -$3.8 million in the prior quarter.
  • The five-year high for Shares Issued was $31.3 million in Q3 2022, with the low at -$3.8 million in Q3 2025.
  • Average Shares Issued over 5 years is $5.6 million, with a median of $132000.0 recorded in 2025.
  • Biggest YoY gain for Shares Issued was 4662.35% in 2025; the steepest drop was 3188.71% in 2025.
  • Tracing DERM's Shares Issued over 5 years: stood at $6800.0 in 2021, then soared by 459826.47% to $31.3 million in 2022, then tumbled by 85.71% to $4.5 million in 2023, then crashed by 97.23% to $124000.0 in 2024, then grew by 6.45% to $132000.0 in 2025.
  • Per Business Quant, the three most recent readings for DERM's Shares Issued are $132000.0 (Q4 2025), -$3.8 million (Q3 2025), and $4.0 million (Q1 2025).